The neurosurgery devices and equipment market size has grown rapidly in recent years. It will grow from $9.56 billion in 2025 to $10.88 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to increasing incidence of neurological disorders, expansion of complex brain and spinal surgeries, rising demand for improved surgical outcomes, availability of advanced imaging technologies, growth in specialized neurosurgical centers.
The neurosurgery devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $18.55 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increasing investments in robotic neurosurgery platforms, rising adoption of AI-assisted surgical planning tools, expansion of outpatient neurosurgical procedures, growing focus on real-time intraoperative imaging, increasing demand for advanced neurosurgical training technologies. Major trends in the forecast period include increasing adoption of image-guided neurosurgical systems, rising use of minimally invasive neurosurgical tools, growing integration of robotic-assisted neurosurgery, expansion of advanced navigation and visualization platforms, enhanced focus on surgical precision and safety.
The rising geriatric population is fueling the growth of the neurosurgery devices market. The geriatric population includes individuals aged 65 years and above, who are more prone to age-related neurological and degenerative conditions. The expansion of the geriatric population is attributed to increased life expectancy and improved overall survival, leading to a higher share of older adults within the population. Neurosurgery devices aid the geriatric population by facilitating surgical treatment, disease management, and functional recovery for conditions such as Alzheimer’s disease, Parkinson’s disease, and stroke-related complications. For example, in June 2024, according to the United Nations Department of Economic and Social Affairs, a US-based international organization, by the mid-2030s there will be 265 million individuals aged 80 and above, surpassing the number of infants, and even rapidly growing countries will witness an increase in the elderly population over the next 30 years. Therefore, the growth in the geriatric population is contributing significantly to the expansion of the neurosurgery devices market.
Major companies operating in the neurosurgery devices and equipment market are emphasizing image-guided surgical systems to improve procedural precision and minimize tissue trauma. Image-guided surgical systems are devices that combine real-time imaging and navigation technologies to help neurosurgeons accurately identify and treat pathological regions while reducing damage to adjacent healthy tissue. For example, in March 2024, Royal Philips, a Netherlands-based healthcare technology company, introduced the Azurion Neuro biplane interventional platform, which offers high-resolution 2D/3D imaging, optimized X-ray detector positioning for complex neurovascular procedures, and ClarityIQ low-dose imaging to lower patient exposure. This platform allows neurosurgeons to carry out precise endovascular interventions, including aneurysm repair and stroke treatment, while enhancing patient safety and workflow efficiency.
In September 2024, Stryker Corporation, a US-based medical technologies company, acquired NICO Corporation for an undisclosed amount. Through this acquisition, Stryker intends to enhance its neurotechnology portfolio by adding NICO’s minimally invasive surgical solutions for intracerebral hemorrhage (ICH) and brain tumor procedures. NICO Corporation is a US-based company recognized for its BrainPath and Myriad access and resection systems designed for deep-seated brain lesions.
Major companies operating in the neurosurgery devices and equipment market are Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Conmed Corporation, Smith & Nephew plc, Integra LifeSciences, Olympus Corporation, Karl Storz GmbH & Co. KG, Richard Wolf GmbH, Johnson & Johnson Services Inc., B. Braun Melsungen AG, Terumo Corporation, Boiotronic Inc., Abbott Laboratories, DePuy Synthes Companies, BrainLAB AG, Zimmer Biomet Holdings Inc., GE Healthcare, NuVasive Inc., ArthroCare Corporation, Vycor Medical Inc., Penumbra Inc., Leica Camera, Carl Zeiss AG, Moller-wedel Optical GmbH, Synaptive Medical Inc., Mizuho OSI, Monteris Medical Inc., NeuroLogica Corporation, NeuroPoint Alliance (NPA), Neurosurgery Research and Education Foundation (NREF), AiM Medical Robotics, Inner Cosmos Inc., AcureX Therapeutics, Novadip Biosciences, Rebstock Instruments GmbH, AKTORmed GmbH.
North America was the largest region in the global neurosurgery devices and equipment market in 2025. Asia-Pacific was the second-largest region in the neurosurgery devices and equipment market. The regions covered in the neurosurgery devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurosurgery devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the neurosurgery devices and equipment market by increasing costs of imported surgical power tools, navigation systems, imaging components, precision instruments, and advanced materials used in neurosurgical procedures. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported high-value equipment, while Asia-Pacific faces pricing pressures on export-oriented manufacturing. These tariffs are raising capital expenditure requirements and delaying equipment upgrades. At the same time, they are encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic production of neurosurgical technologies.
The neurosurgery devices and equipment market research report is one of a series of new reports that provides neurosurgery devices and equipment market statistics, including neurosurgery devices and equipment industry global market size, regional shares, competitors with a neurosurgery devices and equipment market share, detailed neurosurgery devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the neurosurgery devices and equipment industry. This neurosurgery devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurosurgery devices and equipment are specialized medical instruments and technologies used for the diagnosis, treatment, and surgical management of disorders affecting the brain, spine, and nervous system. These devices are crucial in performing surgeries for conditions such as brain tumors, spinal cord injuries, aneurysms, and epilepsy, improving the safety, precision, and outcomes of neurosurgical procedures.
The primary categories of neurosurgery devices and equipment include the neuroendoscope, stereotactic systems, aneurysm clips, neurostimulation devices, cerebrospinal fluid management devices, neurosurgical evacuation devices, neurosurgical navigation systems, neurosurgery surgical power tools, and other specialized equipment such as ultrasonic aspirators and various surgical instruments. The neuroendoscope is a valuable device that allows neurosurgeons to perform less invasive procedures and surgical approaches, minimizing disruption to surrounding tissues. Neurosurgical procedures can be broadly classified into intracranial surgery, endonasal neurosurgery, and spinal surgery, each with its unique set of challenges and requirements. These devices find application in healthcare settings such as hospitals and ambulatory surgical centers.
The neurosurgery devices and equipment market consists of sales of neurostimulation devices, neuroendoscope, cerebrospinal fluid management devices, neurosurgical evacuation device, neurosurgery surgical power tools, ultrasonic aspirators, and surgical instruments. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neurosurgery devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $18.55 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increasing investments in robotic neurosurgery platforms, rising adoption of AI-assisted surgical planning tools, expansion of outpatient neurosurgical procedures, growing focus on real-time intraoperative imaging, increasing demand for advanced neurosurgical training technologies. Major trends in the forecast period include increasing adoption of image-guided neurosurgical systems, rising use of minimally invasive neurosurgical tools, growing integration of robotic-assisted neurosurgery, expansion of advanced navigation and visualization platforms, enhanced focus on surgical precision and safety.
The rising geriatric population is fueling the growth of the neurosurgery devices market. The geriatric population includes individuals aged 65 years and above, who are more prone to age-related neurological and degenerative conditions. The expansion of the geriatric population is attributed to increased life expectancy and improved overall survival, leading to a higher share of older adults within the population. Neurosurgery devices aid the geriatric population by facilitating surgical treatment, disease management, and functional recovery for conditions such as Alzheimer’s disease, Parkinson’s disease, and stroke-related complications. For example, in June 2024, according to the United Nations Department of Economic and Social Affairs, a US-based international organization, by the mid-2030s there will be 265 million individuals aged 80 and above, surpassing the number of infants, and even rapidly growing countries will witness an increase in the elderly population over the next 30 years. Therefore, the growth in the geriatric population is contributing significantly to the expansion of the neurosurgery devices market.
Major companies operating in the neurosurgery devices and equipment market are emphasizing image-guided surgical systems to improve procedural precision and minimize tissue trauma. Image-guided surgical systems are devices that combine real-time imaging and navigation technologies to help neurosurgeons accurately identify and treat pathological regions while reducing damage to adjacent healthy tissue. For example, in March 2024, Royal Philips, a Netherlands-based healthcare technology company, introduced the Azurion Neuro biplane interventional platform, which offers high-resolution 2D/3D imaging, optimized X-ray detector positioning for complex neurovascular procedures, and ClarityIQ low-dose imaging to lower patient exposure. This platform allows neurosurgeons to carry out precise endovascular interventions, including aneurysm repair and stroke treatment, while enhancing patient safety and workflow efficiency.
In September 2024, Stryker Corporation, a US-based medical technologies company, acquired NICO Corporation for an undisclosed amount. Through this acquisition, Stryker intends to enhance its neurotechnology portfolio by adding NICO’s minimally invasive surgical solutions for intracerebral hemorrhage (ICH) and brain tumor procedures. NICO Corporation is a US-based company recognized for its BrainPath and Myriad access and resection systems designed for deep-seated brain lesions.
Major companies operating in the neurosurgery devices and equipment market are Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Conmed Corporation, Smith & Nephew plc, Integra LifeSciences, Olympus Corporation, Karl Storz GmbH & Co. KG, Richard Wolf GmbH, Johnson & Johnson Services Inc., B. Braun Melsungen AG, Terumo Corporation, Boiotronic Inc., Abbott Laboratories, DePuy Synthes Companies, BrainLAB AG, Zimmer Biomet Holdings Inc., GE Healthcare, NuVasive Inc., ArthroCare Corporation, Vycor Medical Inc., Penumbra Inc., Leica Camera, Carl Zeiss AG, Moller-wedel Optical GmbH, Synaptive Medical Inc., Mizuho OSI, Monteris Medical Inc., NeuroLogica Corporation, NeuroPoint Alliance (NPA), Neurosurgery Research and Education Foundation (NREF), AiM Medical Robotics, Inner Cosmos Inc., AcureX Therapeutics, Novadip Biosciences, Rebstock Instruments GmbH, AKTORmed GmbH.
North America was the largest region in the global neurosurgery devices and equipment market in 2025. Asia-Pacific was the second-largest region in the neurosurgery devices and equipment market. The regions covered in the neurosurgery devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurosurgery devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the neurosurgery devices and equipment market by increasing costs of imported surgical power tools, navigation systems, imaging components, precision instruments, and advanced materials used in neurosurgical procedures. Hospitals and surgical centers in North America and Europe are most affected due to reliance on imported high-value equipment, while Asia-Pacific faces pricing pressures on export-oriented manufacturing. These tariffs are raising capital expenditure requirements and delaying equipment upgrades. At the same time, they are encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic production of neurosurgical technologies.
The neurosurgery devices and equipment market research report is one of a series of new reports that provides neurosurgery devices and equipment market statistics, including neurosurgery devices and equipment industry global market size, regional shares, competitors with a neurosurgery devices and equipment market share, detailed neurosurgery devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the neurosurgery devices and equipment industry. This neurosurgery devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurosurgery devices and equipment are specialized medical instruments and technologies used for the diagnosis, treatment, and surgical management of disorders affecting the brain, spine, and nervous system. These devices are crucial in performing surgeries for conditions such as brain tumors, spinal cord injuries, aneurysms, and epilepsy, improving the safety, precision, and outcomes of neurosurgical procedures.
The primary categories of neurosurgery devices and equipment include the neuroendoscope, stereotactic systems, aneurysm clips, neurostimulation devices, cerebrospinal fluid management devices, neurosurgical evacuation devices, neurosurgical navigation systems, neurosurgery surgical power tools, and other specialized equipment such as ultrasonic aspirators and various surgical instruments. The neuroendoscope is a valuable device that allows neurosurgeons to perform less invasive procedures and surgical approaches, minimizing disruption to surrounding tissues. Neurosurgical procedures can be broadly classified into intracranial surgery, endonasal neurosurgery, and spinal surgery, each with its unique set of challenges and requirements. These devices find application in healthcare settings such as hospitals and ambulatory surgical centers.
The neurosurgery devices and equipment market consists of sales of neurostimulation devices, neuroendoscope, cerebrospinal fluid management devices, neurosurgical evacuation device, neurosurgery surgical power tools, ultrasonic aspirators, and surgical instruments. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neurosurgery Devices and Equipment Market Characteristics
3. Neurosurgery Devices and Equipment Market Supply Chain Analysis
4. Global Neurosurgery Devices and Equipment Market Trends and Strategies
5. Neurosurgery Devices and Equipment Market Analysis of End Use Industries
7. Global Neurosurgery Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neurosurgery Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Neurosurgery Devices and Equipment Market Segmentation
10. Neurosurgery Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Neurosurgery Devices and Equipment Market
12. China Neurosurgery Devices and Equipment Market
13. India Neurosurgery Devices and Equipment Market
14. Japan Neurosurgery Devices and Equipment Market
15. Australia Neurosurgery Devices and Equipment Market
16. Indonesia Neurosurgery Devices and Equipment Market
17. South Korea Neurosurgery Devices and Equipment Market
18. Bangladesh Neurosurgery Devices and Equipment Market
19. Thailand Neurosurgery Devices and Equipment Market
20. Vietnam Neurosurgery Devices and Equipment Market
21. Malaysia Neurosurgery Devices and Equipment Market
22. Singapore Neurosurgery Devices and Equipment Market
23. Philippines Neurosurgery Devices and Equipment Market
24. Hong Kong Neurosurgery Devices and Equipment Market
25. New Zealand Neurosurgery Devices and Equipment Market
26. Taiwan Neurosurgery Devices and Equipment Market
27. South East Asia Neurosurgery Devices and Equipment Market
28. Western Europe Neurosurgery Devices and Equipment Market
29. UK Neurosurgery Devices and Equipment Market
30. Germany Neurosurgery Devices and Equipment Market
31. France Neurosurgery Devices and Equipment Market
32. Italy Neurosurgery Devices and Equipment Market
33. Spain Neurosurgery Devices and Equipment Market
34. Austria Neurosurgery Devices and Equipment Market
35. Belgium Neurosurgery Devices and Equipment Market
36. Denmark Neurosurgery Devices and Equipment Market
37. Finland Neurosurgery Devices and Equipment Market
38. Ireland Neurosurgery Devices and Equipment Market
39. Netherlands Neurosurgery Devices and Equipment Market
40. Norway Neurosurgery Devices and Equipment Market
41. Portugal Neurosurgery Devices and Equipment Market
42. Sweden Neurosurgery Devices and Equipment Market
42. Switzerland Neurosurgery Devices and Equipment Market
43. Eastern Europe Neurosurgery Devices and Equipment Market
44. Russia Neurosurgery Devices and Equipment Market
45. Czech Republic Neurosurgery Devices and Equipment Market
46. Poland Neurosurgery Devices and Equipment Market
47. Romania Neurosurgery Devices and Equipment Market
48. Ukraine Neurosurgery Devices and Equipment Market
49. North America Neurosurgery Devices and Equipment Market
50. USA Neurosurgery Devices and Equipment Market
51. Canada Neurosurgery Devices and Equipment Market
52. Mexico Neurosurgery Devices and Equipment Market
53. South America Neurosurgery Devices and Equipment Market
54. Brazil Neurosurgery Devices and Equipment Market
55. Chile Neurosurgery Devices and Equipment Market
56. Argentina Neurosurgery Devices and Equipment Market
57. Colombia Neurosurgery Devices and Equipment Market
58. Peru Neurosurgery Devices and Equipment Market
59. Middle East Neurosurgery Devices and Equipment Market
60. Saudi Arabia Neurosurgery Devices and Equipment Market
61. Israel Neurosurgery Devices and Equipment Market
62. Iran Neurosurgery Devices and Equipment Market
63. Turkey Neurosurgery Devices and Equipment Market
64. United Arab Emirates Neurosurgery Devices and Equipment Market
65. Africa Neurosurgery Devices and Equipment Market
66. Egypt Neurosurgery Devices and Equipment Market
67. Nigeria Neurosurgery Devices and Equipment Market
68. South Africa Neurosurgery Devices and Equipment Market
70. Neurosurgery Devices and Equipment Market Competitive Landscape and Company Profiles
71. Neurosurgery Devices and Equipment Market Other Major and Innovative Companies
74. Neurosurgery Devices and Equipment Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Neurosurgery Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neurosurgery devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neurosurgery devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurosurgery devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Neuroendoscope; Stereotactic Systems; Aneurysm Clips; Neurostimulation Devices; Cerebrospinal Fluid Management Devices; Neurosurgical Evacuation Device; Neurosurgical Navigation Systems; Neurosurgery Surgical Power Tools; Other Device Types2) By Surgery Type: Intracranial Surgery; Endonasal Neurosurgery; Spinal Surgery
3) By End User: Hospitals; Ambulatory Surgical Centers
Subsegments:
1) By Neuroendoscope: Rigid Neuroendoscopes; Flexible Neuroendoscopes2) By Stereotactic Systems: Frame-based Systems; Frameless Systems
3) By Aneurysm Clips: Titanium Aneurysm Clips; Stainless Steel Aneurysm Clips
4) By Neurostimulation Devices: Spinal Cord Stimulation (SCS) Devices; Deep Brain Stimulation (DBS) Devices; Vagus Nerve Stimulation (VNS) Devices; Sacral Nerve Stimulation (SNS) Devices
5) By Cerebrospinal Fluid (CSF) Management Devices: Shunts; Drainage Systems
6) By Neurosurgical Evacuation Devices: Hematoma Evacuation Devices; Suction Evacuation Systems
7) By Neurosurgical Navigation Systems: Optical Navigation Systems; Electromagnetic Navigation Systems; Hybrid Navigation Systems
8) By Neurosurgery Surgical Power Tools: Drills; Saws; Shavers
9) By Other Device Types: Ultrasonic Aspirators; Surgical Instruments
Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Stryker Corporation; Conmed Corporation; Smith & Nephew plc; Integra LifeSciences; Olympus Corporation; Karl Storz GmbH & Co. KG; Richard Wolf GmbH; Johnson & Johnson Services Inc.; B. Braun Melsungen AG; Terumo Corporation; Boiotronic Inc.; Abbott Laboratories; DePuy Synthes Companies; BrainLAB AG; Zimmer Biomet Holdings Inc.; GE Healthcare; NuVasive Inc.; ArthroCare Corporation; Vycor Medical Inc.; Penumbra Inc.; Leica Camera; Carl Zeiss AG; Moller-wedel Optical GmbH; Synaptive Medical Inc.; Mizuho OSI; Monteris Medical Inc.; NeuroLogica Corporation; NeuroPoint Alliance (NPA); Neurosurgery Research and Education Foundation (NREF); AiM Medical Robotics; Inner Cosmos Inc.; AcureX Therapeutics; Novadip Biosciences; Rebstock Instruments GmbH; AKTORmed GmbH
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neurosurgery Devices and Equipment market report include:- Medtronic plc
- Boston Scientific Corporation
- Stryker Corporation
- Conmed Corporation
- Smith & Nephew plc
- Integra LifeSciences
- Olympus Corporation
- Karl Storz GmbH & Co. KG
- Richard Wolf GmbH
- Johnson & Johnson Services Inc.
- B. Braun Melsungen AG
- Terumo Corporation
- Boiotronic Inc.
- Abbott Laboratories
- DePuy Synthes Companies
- BrainLAB AG
- Zimmer Biomet Holdings Inc.
- GE Healthcare
- NuVasive Inc.
- ArthroCare Corporation
- Vycor Medical Inc.
- Penumbra Inc.
- Leica Camera
- Carl Zeiss AG
- Moller-wedel Optical GmbH
- Synaptive Medical Inc.
- Mizuho OSI
- Monteris Medical Inc.
- NeuroLogica Corporation
- NeuroPoint Alliance (NPA)
- Neurosurgery Research and Education Foundation (NREF)
- AiM Medical Robotics
- Inner Cosmos Inc.
- AcureX Therapeutics
- Novadip Biosciences
- Rebstock Instruments GmbH
- AKTORmed GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 10.88 Billion |
| Forecasted Market Value ( USD | $ 18.55 Billion |
| Compound Annual Growth Rate | 14.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 38 |
